Fibrocystic breast changes don't always cause symptoms. ACR Appropriateness Criteria ® Palpable Breast Masses. Radiologic and Pathologic Correlation for Benign Breast Processes. | Open in Read by QxMDĬheung H, Parker EU, Yu M, Kilgore MR, Lam DL. Nonmass Findings at Breast US: Definition, Classifications, and Differential Diagnosis. | Open in Read by QxMDĬhoe J, Chikarmane SA, Giess CS. Mimickers of Breast Malignancy on Breast Sonography.
Characteristics and Management of Male Breast Parenchymal Cysts. Maimone S, Ocal IT, Robinson KA, Wasserman MC, Maxwell RW. Rinaldi P, Ierardi C, Costantini M, et al. Clustered Microcysts at Breast US: Outcomes and Updates for Appropriate Management Recommendations.
Sclerosing adenosis and risk of breast cancer. Fibrocystic Changes of the Breast: Radiologic–Pathologic Correlation of MRI. 2018 43Ĭhoe AI, Kasales C, Mack J, Al-Nuaimi M, Karamchandani DM. Subtypes of Benign Breast Disease as a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis Protocol. Zendehdel M, Niakan B, Keshtkar A, Rafiei E, Salamat F. 164 Diagnosis and management of benign breast disorders. Imaging and needle biopsy findings are discordant.ĪCOG.CNB findings suggestive of radial scar, atypical hyperplasia.Excisional biopsy: Consider in the following situations.Core needle biopsy ( CNB): preferred for most lesions.In patients with suspicious clinical and/or imaging findings, a tissue biopsy is indicated to rule out malignancy.” See “Histologic subtypes” for findings Low-intensity T1 weighted round or oval masses.Isointense or hypointense masses with fluid components.MRI breast with and without contrast (not routinely obtained) Round or oval masses with circumscribed borders.Simple or complicated cysts (see “ Breast cysts” for details).
The imaging findings in fibrocystic breast changes are heterogeneous and include the following. Imagingįollow age-appropriate diagnostic workup for a palpable breast mass. See also “ Breast mass,” “ Mastalgia,” “ Nipple discharge,” and “ Breast cysts” as needed.Īll patients with a palpable breast mass should be evaluated appropriately, even those with suspected fibrocystic breast changes.Diagnostic workup should be guided by clinical findings.Obtain a thorough medical history and perform a CBE in all patient.Proliferative breast lesions with cellular atypia require surgical excision as they are associated with an increased risk of breast cancer. Management of breast lesions without cellular atypia is primarily symptomatic. Tissue biopsy, usually a core-needle biopsy, is indicated if there is a clinical suspicion of malignancy. The diagnosis is made during the workup of symptoms (e.g., mastalgia, palpable breast mass, nipple discharge) or incidentally on clinical breast examination and/or imaging. Patients typically present with premenstrual bilateral multifocal breast pain with or without palpable nodules, which may be tender. Histologically, fibrocystic changes are divided into nonproliferative breast lesions (e.g., simple breast cysts, apocrine metaplasia) and proliferative breast lesions (e.g., ductal epithelial hyperplasia, sclerosing adenosis). Women between 20 and 50 years of age are most commonly affected. Fibrocystic breast changes is a nonspecific term that includes a heterogeneous spectrum of breast conditions.
0 kommentar(er)
